FTM
ITCI

First Turn Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

First Turn Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-294,414
Closed -$24.6M – 44
2024
Q4 		$24.6M Buy
294,414
+39,614
+16% +$3.26M 4.4% 5
2024
Q3 		$18.6M Sell
254,800
-92,543
-27% -$6.96M 2.95% 10
2024
Q2 		$23.8M Buy
347,343
+140,636
+68% +$9.75M 3.87% 6
2024
Q1 		$14.3M Sell
206,707
-10,718
-5% -$737K 2.14% 26
2023
Q4 		$15.6M Buy
+217,425
New +$12.5M 2.24% 24

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

First Turn Management's ITCI Position: Q1 2025 in Review

First Turn Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 294,414 shares — an estimated $24.6M sold.

First Turn Management first reported a position in ITCI in Q4 2023 and held it in 5 quarters. The position peaked at $24.6M in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • First Turn Management reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • First Turn Management sold 294,414 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $24.6M.
  • First Turn Management first reported a position in Intra-Cellular Therapies Inc. in Q4 2023 and held it in 5 quarters.
  • First Turn Management's Intra-Cellular Therapies Inc. position peaked at $24.6M in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on First Turn Management's 13F filing for Q1 2025, filed 15 May 2025.